Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 21, 2019
New research uncovers how common genetic mutation drives cancer
Findings in Nature show that targeted therapy for mutated gene can slow or prevent tumor growth in many kinds of cancer
How a common cancer mutation actually drives cancer — and how to correct it
High-tech approach solves ‘real mystery’ in many cancers
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
The lung cancer blame game
The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
Reawakening the X chromosome: New possible therapeutic targets for rare neurological disorder
Study points to potential reversal of rare childhood neurological disorder by reactivating silenced copy of the disease-linked gene
Common genetic disorder linked to increased death rate from cancer drug
Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
New technique reveals cells’ tiny engines unexpectedly shrug off DNA damage from toxic chemicals
A precise new technique reveals that our cells’ engines, mitochondria, unexpectedly shrug off DNA damage from toxic chemicals
Good News at Fred Hutch: Dr. Anne McTiernan named to HHS panel; Dr. Harlan Robins is co-PI on two projects
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
More than the 'Angelina Jolie Effect': BRCA testing spikes among breast cancer patients
Search for gene mutations began rising before actress revealed surgeries; better insurance coverage, access cited by experts
Testing without context
Nearly two-thirds of women who get tested for BRCA mutations don’t receive genetic counseling first
Good News at Fred Hutch
Public health researchers get $4 million grant to study aggressive type of colorectal cancer; Core Center of Hematology designated as national core resource
Genetic Variability May Predict Severity of Side Effects From Methotrexate, A Common Chemotherapy Drug
DNA screening tool may be useful in tailoring treatments for cancer and other diseases
Hutchinson Center Receives $1.2 Million From National Science Foundation to Study Plant Genetics
New strategy obtains useful genetic mutations in plants with no transgenic manipulations